Renal Sympathetic Denervation Prevents Atrial Fibrillation in Patients With Hypertensive Heart Disease: a Pilot Study

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

June 6, 2022

Study Completion Date

June 6, 2022

Conditions
HypertensionHypertensive Heart DiseaseAtrial FibrillationAutonomic Imbalance
Interventions
DEVICE

Renal denervation

In patients randomized to intervention both renal arteries will be treated with radio-frequency energy as per standard Symplicity protocol.In patients randomized to medical-treatment group only, sham renal denervation will be performed by only injecting contrast agent into both renal arteries.

DRUG

Medical therapy

Subjects will continue on their standard medical therapy as prescribed by their treating physician

Trial Locations (1)

7505

Pace Clinic, Cape Town

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

University Hospital, Saarland

OTHER

lead

Pace Clinic

OTHER